# LOMUSTINE
> **ANDA219265** · Abbreviated New Drug Application (Generic) · Sponsor: CARNEGIE · Approved 2025-10-27
## Drug
- **FDA Application Number:** ANDA219265
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOMUSTINE
- **Generic name:** LOMUSTINE
- **Active ingredients:** LOMUSTINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CARNEGIE
- **Manufacturer:** Carnegie Pharmaceuticals LLC
- **First approval:** 2025-10-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219265)
---
*MORVS · CC0 1.0*